Updated view of fibromyalgia

Czech version

Authors: Jan Tomš
Authors‘ workplace: Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové, 2. interní klinika FN, Oddělení revmatologie a klinické farmakologie
Published in: Čas. Lék. čes. 2012; 151: 415-419
Category: Review Articles

Overview

Fibromyalgia is a chronic syndrome characterized by dysfunction of pain processing and regulation. Although the definite etiology has not been recognized yet, the key role in the pathogenesis of this syndrome probably plays the central sensitization process with the development of chronic (central) pain and other associated symptoms (fatigue, stiffness, sleep disorders, cognitive and vegetative disturbance). The absence of objective diagnostic tests often results in delayed diagnosis and patient fluctuation among a number of specialists with uncertainty and fear of a serious disease. The treatment is based on the individually adjusted and multidisciplinary approach to the patient, combining pharmacological and non-pharmacological therapy. New drugs introduced to the therapy in the recent years can have positive effect on symptom reduction and improvement of patients’ quality of life.

Key words:
fibromyalgia, chronic pain, fatigue, central sensitization.

Sources

1. Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep 2004; 8: 369–378.

2. Wolfe F, Smythe A, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160–172.

3. Csillage C. Fibromyalgia: the Copenhagen declaration. Lancet 1992; 340: 663–664.

4. Tomš J, Soukup T, Bradna P, Hrnčíř Z. Konkomitující fibromyalgie u pacientů s revmatoidní artritidou. Čes Revmatol 2009; 17(3): 120–126.

5. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36: 339–356.

6. Croft P, Rigby AS, Boswell R, et al. The prevalence of chronic widespread pain in the general population. J Rheumatol 1993; 20: 710–713.

7. Lindell L, Bergman S, Petersson IF, et al. Prevalence of fibromyalgia and chronic wide–spread pain. Scand J Prim Health Care 2000; 18: 149–153.

8. White KP, Harth M. Classification, epidemiology and natural history of fibromyalgia. Curr Pain Headache Rep 2001; 53: 320–329.

9. Schanberg L. Widespread pain in children: when is it pathologic? Arthritis Rheum 2003; 48: 2402–2405.

10. Bennett RM. The fibromyalgia syndrome. In: Kelley WN, Harris ED, Ruddy S, et al. Textbook of rheumatology, 5th ed. Philladelphia: W.B. Saunders 1997; 511–519.

11. Price DD, Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol 2005; 75(Suppl): 22–28.

12. Tomš J. Současný pohled na etiopatogenezi fibromyalgie. Čes Revmatol 2009; 17(3): 162–166.

13. Gowers WR. Lumbago: Its lessons and analogues. Br Med J 1904; 1: 117–121.

14. Stockman R. Rheumatism and arthritis. Edinburgh: Green and Son Ltd. 1920; 132.

15. Yunus MB, Kalyan-Raman UP, Masi AT, et al. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 1989; 16: 97–101.

16. Gebhart GF. Descending modulation of pain. Neurosci Biobehav 2004; 27: 729–737.

17. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994; 11: 1593–1601.

18. Russell IJ, Vaeroy H, Javors M, et al. Cerebrospinal fluid biogenic aminometabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550–556.

19. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944–592.

20. Vargas-Alarcón G, Fragoso JM, et al. Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 2007; 9: R110.

21. Wolfe F, Clauw DJ, Fitzcharles M, et al. The American College fo Rheumatology Preliminary Diagnostic Criteria fo Fibromyalgia and measurement of Symptom Severity. Arthritis Care Res 2010; 62(5): 600–610.

22. Hrnčíř Z, Dvořák Z. Fibromyalgie a chronický únavový syndrom. In: Pavelka K, Rovenský J et al. Klinická revmatologie, Galén, Praha, 2003; 679–684.

23. Bennett RM, Jones J, Turk DC, et al. An internet survey of 2596 people with fibromyalgia. BMC Musculoskeletal Disorders 2007; 8: 27–37.

24. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008; 67(4): 536–541.

25. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292: 2388–2395.

26. Votavová M, Pavelka K. Současné možnosti léčby fibromyalgie. Remedia 2009; 4: 251–255.

27. Arnold LM, Keck PE. Antidepressant treatment of fibromyalgia: a meta–analysis and review. Psychosomatics 2000; 41: 104–113.

28. Croford LJ, Rowbotham MS, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome. Results of randomised, double blind placebo controlled trial. Arthritis Rheum 2005; 52: 1264–1273.

29. Jeřábek J. Fibromyalgie 2009 – kde, jak a proč může pomoci fyzikální léčba. Rehabil Fyz Lék 2009; 2: 60–68.

30. Forseth KĮ, Gran JT, Husby G. A population study of incidence of fibromyalgia among women aged 26–55 yr. Br J Rheumatol 1997; 36: 1318–1323.

31. Granges G, Zilko P, Littlejohn GO. Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 1994; 21: 523–529.

32. Wolfe F, Hassett AL, Wallitt B, et al. Mortality in Fibromyalgia: A Study of 8186 Patients Over Thirty-Five Years. Arthritis Care Res 2011; 63(1): 94–101.

Labels

Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management

General psychopathology

Phytotherapy of skin wounds – overview of experimental and clinical studies in the first decennium of the 21st century

Tretament of tobacco dependence – improving availability in the clinical practice

The importance of DNA analysis of C282Y, H63D and S65C mutations in the HFE gene

Article was published in

Journal of Czech Physicians

2012 Issue 9

Download issue PDF